Vijay Reddy Peddareddigari

Vijay Reddy Peddareddigari

Company: Tmunity Therapeutics

Job title: Chief Research & Development Officer


Overcoming CAR-T Toxicity with Next Generation T-Cell Reprogramming 1:30 pm

Highly potent and armoured CAR-T cells are necessary of inducing responses in solid tumours. This increases the risk of on-target off-tumour toxicity as well as severe immunotoxicity Additionally, the unique solid tumour microenvironment can amplify cytokine release syndrome We have engineered a next generation armoured CAR-T that has the potential to have lower risk of…Read more

day: Day 1 – Track B – Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.